Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors

Autor:	A. Arribas, S. Vultaggio, A. Andronache, M. Robusto, D. Fancelli, E. Cannas, F. Spriano, C. Tarantelli, D. Rossi, E. Zucca, A. Stathis, M. Varasi, C. Mercurio, F. Bertoni
Rok vydání:	2022
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 174:S108
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::622c369d3104505e4ae6d3ec56f96378 https://doi.org/10.1016/s0959-8049(22)01088-7 Zobrazit plný text záznamu Full Text from ScienceDirect